Estradiol
Who holds supplier records for Estradiol? 15 organisations hold a current record for Estradiol: an active US FDA Type II Drug Master File or a CEP. A further 7 organisations have only historical (inactive) DMF filings. 12 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (6), China (3), Germany (2), Netherlands (1) and 2 other countries (2); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Estradiol: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/estradiol
Reading the evidence
- 15 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 7 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Estradiol expires 2 Feb 2034. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (15)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Estradiol. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ASPEN OSS BVNetherlandsCEP Company GMP cert on recordActive DMF 3829 · latest filing May 1980
- Bayer AGGermanyCEP Company GMP cert on recordActive DMF 4684 · latest filing Oct 1982
- Gedeon RichterHungaryCEP Company GMP cert on recordActive DMF 4066 · latest filing Jan 1981
- SYMBIOTEC PHARMALAB PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 34147 · latest filing Sept 2019
- VALDEPHARMFranceCEP Company GMP cert on recordActive DMF 22972 · latest filing Jul 2009
- ZHEJIANG XIANJU PHARMACEUTICAL CO LTDCEPActive DMF 23942 · latest filing Jun 2010
- Hubei Gedian Humanwell Pharmaceutical Co. LtdChina Company GMP cert on recordActive DMF 43561 · latest filing Feb 2026
- Lupin LimitedIndia Company GMP cert on recordActive DMF 25816 · latest filing Apr 2012
- Yangzhou Aurisco Pharmaceutical Co.,Ltd.ChinaActive DMF 43951 · latest filing Mar 2026
- ARESKO LIFE SCIENCES PRIVATE LIMITEDIndiaCEP
- La Chandra Pharmalab Private LimitedIndiaCEP
- Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.ChinaCEP
- SHAKTI LIFESCIENCE PRIVATE LIMITEDIndiaCEP
- IndiaCEP
- SCHMITT PHARMA GMBHGermanyCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (12)
Certificates of Suitability on the EDQM register for Estradiol, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 18 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| SWATI SPENTOSE PRIVATE LIMITED Mumbai | IN | CEP 2026-049 - Rev 00 Estradiol hemihydrate | Jul 2026 | — |
| LA CHANDRA PHARMALAB PRIVATE LIMITED Ahmedabad | IN | CEP 2026-100 - Rev 00 Estradiol hemihydrate, Micronised, Process-2 | Jun 2026 | — |
| SYMBIOTEC PHARMALAB LIMITED Indore | IN | CEP 2020-067 - Rev 01 Estradiol hemihydrate, Micronised | Apr 2026 | Inspected Mar 2026 Germany |
| SHAANXI HANJIANG PHARMACEUTICAL GROUP CO., LTD. Hanzhong | CN | CEP 2023-179 - Rev 01 Estradiol hemihydrate, Process B, micronised | Mar 2026 | — |
| ARESKO LIFE SCIENCES PRIVATE LIMITED Ramnagar | IN | CEP 2024-230 - Rev 00 Estradiol hemihydrate | Feb 2026 | — |
| SCHMITT PHARMA GMBH Kleinmachnow | DE | CEP 2025-211 - Rev 00 Estradiol hemihydrate | Jan 2026 | — |
| GEDEON RICHTER PLC. Budapest | HU | CEP 2025-255 - Rev 00 Estradiol hemihydrate, Dorog site | Oct 2025 | Inspected Jun 2026 Hungary |
| SHAKTI LIFESCIENCE PRIVATE LIMITED Boisar | IN | CEP 2022-286 - Rev 00 Estradiol hemihydrate | Aug 2024 | — |
| ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. Xianju | CN | CEP 2022-220 - Rev 01 Estradiol hemihydrate, Micronised and non-micronised | Jun 2024 | — |
| VALDEPHARM Val de Reuil | FR | CEP 2009-241 - Rev 06 Estradiol hemihydrate, Micronised fine, non-micronised | Sept 2023 | Inspected Dec 2024 France |
| BAYER AG Leverkusen | DE | R2-CEP 1995-017 - Rev 04 Estradiol hemihydrate | Mar 2017 | — |
| ASPEN OSS B.V. Oss | NL | R2-CEP 1995-001 - Rev 03 Estradiol hemihydrate | Jan 2014 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (7)
Organisations whose Type II DMFs for Estradiol are no longer active. These show a past filing, not current supply.
Show all 7 historical records
- Zhejiang Xianju Junye Pharmaceutical Co., Ltd.(Yangfu site)China · Inactive DMF 24192 · filed Oct 2010
- BEIJING KEYIFENG BIOTECH DEVELOPMENT CO LTDInactive DMF 24085 · filed Aug 2010
- United States · Inactive DMF 10536 · filed Oct 1993
- ROUSSELL UCLAFInactive DMF 8819, 5686 · filed Nov 1990
- India · Inactive DMF 6946 · filed Apr 1987
- MITSUBISHI CHEMICAL INDUSTRIES LTDInactive DMF 3175 · filed Mar 1978
- United States · Inactive DMF 2677 · filed May 1976
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (121 listed products contain Estradiol). The latest listed patent expires 2 Feb 2034. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Estradiol is a form of estrogen, a female sex hormone that regulates many processes in the body. It is used in hormone replacement therapy for menopausal symptoms and also in certain cancer treatments.
Chemical identity
- IUPAC name
- (8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
- Canonical SMILES
- C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)O
- InChIKey
- VOXZDWNPVJITMN-LEKSSAKUSA-N
- Synonyms
- Estrace API, 17 β-estradiol, 17-.beta.-oestradiol, 17-beta-oestradiol, 17.beta.-estradiol, 17beta-estradiol, activella component estradiol, aerodiol, alora, angeliq component estradiol, bijuva component estradiol, climara
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Estrogen
- Mechanism of action
- Estrogen Receptor Agonists
- Chemical structure
- Estradiol Congeners
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Estradiol?
15 organisations hold an active US FDA Type II Drug Master File or a CEP for Estradiol: ASPEN OSS BV (Netherlands), Bayer AG (Germany), Gedeon Richter (Hungary), SYMBIOTEC PHARMALAB PRIVATE LTD (India), VALDEPHARM (France), ZHEJIANG XIANJU PHARMACEUTICAL CO LTD, Hubei Gedian Humanwell Pharmaceutical Co. Ltd (China) and Lupin Limited (India), and 7 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Estradiol Drug Master Files are active?
ASPEN OSS BV (DMF 3829), Bayer AG (DMF 4684), Gedeon Richter (DMF 4066), SYMBIOTEC PHARMALAB PRIVATE LTD (DMF 34147), VALDEPHARM (DMF 22972), ZHEJIANG XIANJU PHARMACEUTICAL CO LTD (DMF 23942), Hubei Gedian Humanwell Pharmaceutical Co. Ltd (DMF 43561) and Lupin Limited (DMF 25816) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Estradiol records mean?
7 organisations have only inactive Type II DMFs for Estradiol. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Estradiol have a European Certificate of Suitability?
Yes. 12 organisations hold a valid CEP for Estradiol on the EDQM register, including SWATI SPENTOSE PRIVATE LIMITED Mumbai (IN), LA CHANDRA PHARMALAB PRIVATE LIMITED Ahmedabad (IN), SYMBIOTEC PHARMALAB LIMITED Indore (IN), SHAANXI HANJIANG PHARMACEUTICAL GROUP CO., LTD. Hanzhong (CN), ARESKO LIFE SCIENCES PRIVATE LIMITED Ramnagar (IN) and SCHMITT PHARMA GMBH Kleinmachnow (DE) and 6 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Estradiol?
Yes. The latest patent listed for an approved US product containing Estradiol expires 2 Feb 2034, across 121 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Estradiol supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Estradiol?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.